The Webinar Training Pass

Now get all the training you need – all in one place, and all for one low price!

The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.

PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!

If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.

Select webinars have been pre-approved by RAPS as eligible for up to 1.5 credits toward a participant’s RAC recertification. Please enter keyword RAPS below for a list of eligible on-demand webinars.

Already have an account?   Login Here.

Webinar Training Pass

Recorded on: Aug. 15, 2018

Description: FDA specialist Sonali P. Gunawardhana and clinical research expert Mary Jo Lamberti discuss the evolution of real-world evidence (RWE) in clinical studies and the FDA’s policies and priorities. Topics include:

  • Ways drugmakers are using RWE to support promotional claims and premarket applications;
  • Impact of recent FDA statements on including RWE in approval and clearance applications and as a basis for drug and device promotional claims; and
  • How the agency may use RWE to support regulatory decisionmaking.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Sonali P. Gunawardhana, Of Counsel, Shook, Hardy & Bacon LLP, and Mary Jo Lamberti, Professor and Associate Director of Sponsored Research, Tufts Center for the Study of Drug Development

Recorded on: Aug. 14, 2018

Description: Device regulatory expert Dan O’Leary explains the FDA’s new MDR coding regimen. He discusses:

  • Criteria for a mandatory medical device report;
  • Required records and their content;
  • The reporting system and associated acknowledgements; and
  • The schedule for transitioning to the new system.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Dan O’Leary, President, Ombu Enterprises LLC

Recorded on: Aug. 1, 2018

Description: Regulatory expert Bradley Merrill Thompson outlines how the FDA has regulated digital health products to date and what it plans in months to come. He discusses:

  • AI-powered clinical decision support software;
  • Postmarket surveillance;
  • Cooperation with industry; and
  • Premarket digital safety.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Bradley Merrill Thompson, Attorney, Epstein Becker & Green P.C.

Recorded on: July 31, 2018

Description: European regulatory expert James Pink provides a deep dive into the new EU MDR. He discusses:

  • New requirements for documentation confirmation and updating;
  • New separate software rules;
  • Stricter requirements for implantable devices; and
  • Possible sanctions for devicemakers who are not ready to comply with the new rules.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: James Pink, Vice President, NSF Health Sciences Medical Devices, Europe

Recorded on: July 26, 2018

Description: Attorney Jessica Ringel outlines provisions of the FDA Reauthorization Act of 2017 and their impact on devicemakers. She discusses:

  • Changes in user fees for premarket submissions;
  • Improvements anticipated in the FDA inspections process;
  • How transparency in certificates to foreign governments issuance and denials will increase;
  • Specific FDA efforts to stimulate pediatric device innovation; and
  • New guidances, rules and reports anticipated from the agency in coming years.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Jessica Ringel, Counsel, FDA and Life Sciences Practice, King & Spalding LLP

Recorded on: July 18, 2018

Description: Electronic submissions expert Antoinette Azevedo explains the technical and organization challenges of complying with the FDA’s eCTD specifications:

  • How to avoid a refuse-to-receive when submitting your eCTD;
  • Strategies for developing a roadmap for implementing the technical and organization components for eCTD success;
  • Real world impact of eCTD format on your CMO and CRO partners; and
  • The impact of eCTD on submissions to the rest of the world health authorities.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Antoinette Azevedo, President & CEO, e-SubmissionsSolutions.com

Recorded on: July 17, 2018

Description: FDA official Owen Faris provides a view into FDA’s thinking and activities related to the use of real-world evidence (RWE) and the National Evaluation System for Health Technology (NEST). He discusses:

  • Why the FDA is promoting the use of RWE to evaluate medical devices;
  • Proof of concept as it applies to using RWE for device evaluation; and
  • How RWE and NEST can specifically apply to medical device development.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Owen Faris, Director of the Clinical Trials Program, CDRH

Recorded on: July 11, 2018

Description: Regulatory compliance expert Connie Hoy explains the Medical Device Single Audit Process. She discusses:

  • Using the companion document as a preparation guide;
  • Ensuring your quality system covers specific country requirements;
  • Questions auditors are likely to ask; and
  • How the process differs from FDA inspections and ISO audits.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Connie Hoy, President, Hoy & Associates Regulatory Consulting

Recorded on: June 21, 2018

Description: Clinical research compliance experts Jennifer Mallory and Carrie Hanger provide an overview of changes in the Common Rule set to take effect in January 2019. They discuss:

  • Broad consent for secondary research;
  • Limited and continuing IRB review;
  • Exemptions;
  • Federalwide assurances; and
  • Cooperative research.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Jennifer Mallory and Carrie Hanger, partners, Nelson Mullins Riley & Scarborough

Recorded on: June 20, 2018

Description: Pharmaceutical serialization expert Bill Fletcher discusses emerging trends in serializing drug products, track and trace systems and FDA and global regulation. He covers:

  • Child-to-parent aggregation;
  • Complexities of the Drug Supply Chain Security Act;
  • Traceability based on third-party logistics; and
  • Implementing Electronic Product Code Information Services.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Bill Fletcher, Managing Partner, Pharma Logic Solutions LLC